Typical hemophagocytic syndrome associated with cytomegalovirus infection in an immunocompetent patient: a case report and literature review
Authors:
- 14 December 2023
- journal article
- letter
- Published by Zhejiang University Press in Journal of Zhejiang University-SCIENCE B
- Vol. 24 (12) , 1159-1164
Abstract
摘要 嗜血细胞综合征是一种罕见的因大量免疫细胞不受控制的激活和增殖以及细胞因子风暴引起的致命性疾病。尽管病毒感染是其常见病因,但由巨细胞病毒引起的嗜血细胞综合征较为少见。巨细胞病毒感染通常可在免疫功能低下或缺陷人群中引起系列疾病,而在免疫功能正常人群中多表现为无症状。本文报道了一例免疫功能正常患者感染巨细胞病毒引起嗜血细胞综合征后,经芦可替尼治疗成功好转。本文旨在强调免疫功能正常患者感染巨细胞病毒后可引起严重的嗜血细胞综合征,而及时给予芦可替尼治疗可以显著改善患者预后。同时,应进一步提高临床医师对免疫功能正常人群感染巨细胞病毒的重视,并为临床工作者提供新的诊疗思路。Keywords
This publication has 18 references indexed in Scilit:
- CytomegalovirusMicrobiology Spectrum, 2016
- Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosisBlood, 2016
- Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia VeraNew England Journal of Medicine, 2015
- JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasmsBritish Journal of Haematology, 2015
- Pulmonary tuberculosis reactivation following ruxolitinib treatment in a patient with primary myelofibrosisLeukemia & Lymphoma, 2014
- Reactivation of herpes simplex virus infection in a patient undergoing ruxolitinib treatmentJournal of the American Academy of Dermatology, 2014
- Hepatitis B virus reactivation associated with ruxolitinibAnnals of Hematology, 2013
- The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivoBlood, 2013
- JAK Inhibition with Ruxolitinib versus Best Available Therapy for MyelofibrosisNew England Journal of Medicine, 2012
- Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic reviewVirology Journal, 2008